ProShares UltraPro Nasdaq Biotechnology

ProShares UltraPro Nasdaq Biotechnology

UBIO
ProShares UltraPro Nasdaq BiotechnologyUS flagNASDAQ Global Market
- -
USD
- -
- -

ProShares UltraPro Nasdaq Biotechnology (UBIO) Stock Split History

Learn about ProShares UltraPro Nasdaq Biotechnology's most recent 1-for-5 basis stock split on November 13, 2015. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about ProShares UltraPro Nasdaq Biotechnology's most recent stock split

Split Date: 2015-11-13
Split Ratio: 1:5
Price Before Split: N/A
Price After Split: N/A

Developer API

Get UBIO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/UBIO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 5.00 times fewer shares (a 1:5 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of ProShares UltraPro Nasdaq Biotechnology's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2015-11-131:5YesN/AN/A

About ProShares UltraPro Nasdaq Biotechnology

Company overview and industry information

ProShares UltraPro Nasdaq Biotechnology (UBIO) operates in the Asset Management - Leveraged industry. The recent 1-for-5 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Asset Management - Leveraged
Go to ProShares UltraPro Nasdaq Biotechnology Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.